Universidad de Colima

2 marketed · 1 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Universidad de Colima

What are Universidad de Colima's marketed drugs?

Top marketed products include Oral Electrolytes, Probiotic (Lactobacillus reuteri Prodentis.

What is Universidad de Colima's pipeline?

Universidad de Colima has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include ketamine sedation versus midazolam sedation.

Related